| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > The No 1 Reason Why You Fail to Maintain Your Mailing List |
|
Digg It - The No 1 Reason Why You Fail to Maintain Your Mailing List
It's probably a too common phrase to hear on the internet marketing scene that "the money is in the list", but only to a certain extent if you know how to manage it efficiently, and most importantly, giving the subscribers According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product what they actually want - information, useful information. Not your constant set of recommendations of affiliate products. Having said that, you may have already guessed, that the main reason is nothing other than SELLING ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in TOO MUCH with your list. I'm not in anyway calling myself an experienced list builder or an expert in the internet marketing field, but I'm saying this from a subscriber's perspective and point of view. I would say that lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. 've subscribed to hundreds of lists out of interest of receiving more information closely related to the owner's products or just simply because that's the only way I could access an offer from the site. And yes, I've unsu here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe bscribed almost 70 to 90% of them after being hammered relentlessly with disguised affiliate links. Trust me, anybody could smell that it's an affiliate link even from a distance. Even if you're a well recognized, credible d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro individual, the increasing frequency of selling tones in your mailing emails won't do good for your reputation in the long run. Don't get me wrong here, I'm not saying that you shouldn't subscribe to any mailing lists any ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc more, as there's still a huge number of great individuals who prioritise their subscriber's level of satisfaction, hence giving the reason why they're standing tall today with tens, maybe hundreds of thousands of subscribe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s in their lists. I'm also not in anyway pointing out the fact that you cannot "recommend" products through your list, as I believe some of them do come from really irresistible joint venture offers. Just keep it low, prob nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ably once or twice a month. If you want more, communicate with your subscribers, get their feedback and response in your future plans of increasing the number of offers. If you get an obvious NO to your request, then don't and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ do it. At this point, some of you might say that if the list owners don't send out offers, then how do I get updated with the latest products in the market? You might even miss a great application or ebook which could sav ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e you a great deal of time doing it the conventional way. The answer is simple, there are tones of websites out there which announce and review just recently launched products. Go there and do your background research. For ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ums and blogs do cover this newly launched products as well together with the very much essential user feedbacks and testimonials. Yes those sites will recommend the products with their affiliate links too, but you always dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ave the option not to go through their affiliate link if you don't want to. Gary Halbert, a well known copywriter and "the prince of print", once said that as he was (and still is) constantly giving great free useful info cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin rmation on his website and to his announcement list, his subscribers went to the extent of actually asking him if he had anything to sell so that they could buy it from him. Correct me if I'm wrong, but that's the exact re tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ersed situation of product marketing. Buyers actually marketing themselves as a potential buyer to you, as a seller. And how on Earth did that happen? You can ask Gary Halbert yourself or you could just simply do one simpl t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e thing - reduce your selling emails to your list and start giving useful, concrete, or what others would say, the exact thing what typical subscribers would want - Good Useful Information. Again, as I have mentioned above ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust I'm no expert in anyway to say or advice you on such areas, but don't tell me Gary Halbert isn't. And no, I'm not promoting his website or his services, it's just that I came across the above mentioned situation, expresse y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products d by Gary Halbert himself in his website, which I was greatly impressed of what the consequences were. He is no doubt a living proof that such things do happen. My conclusion - treat your subscribers well, give them what . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hey really want, stop misinterpreting that the money is in the list, and from a single subscriber's point of view, I would say that they will eventually do the same thing to you as what they did to Gary Halbert. Although i elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip t came just merely from a person, I hope that it will somehow open up somebody's eyes that the money is indeed in the list, ONLY if you don't live with the term too religiously and treat it with a logical sense of approach tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Job Hunting Tips: Assessing Personal Value Sales Language: What's Wrong with But?
|